Search clinical trials for: UB-421(25 mg/kg) Q2W
Total 47 results
-
United BioPharmaNational Taiwan University Hospital; Kaohsiung Medical University Chung-Ho... and other collaboratorsCompleted
-
UBP Greater China (Shanghai) Co., LtdNot yet recruiting
-
Jiangsu Alphamab Biopharmaceuticals Co., LtdCompletedGastric/Gastroesophageal Junction CancerChina
-
Suzhou Transcenta Therapeutics Co., Ltd.Completed
-
Suzhou Transcenta Therapeutics Co., Ltd.Completed
-
Sichuan Haisco Pharmaceutical Group Co., LtdCompletedDiabetes Mellitus, Type 2China
-
Merck KGaA, Darmstadt, GermanyCompleted
-
Bausch Health Americas, Inc.CompletedRheumatoid ArthritisUnited States
-
Shanghai Junshi Bioscience Co., Ltd.Active, not recruitingNasopharyngeal Carcinoma | Gastric Adenocarcinoma | Head and Neck Squamous Cell Carcinoma | Esophageal Squamous Cell CarcinomaChina
-
AbbVie (prior sponsor, Abbott)Genentech, Inc.CompletedNon-Small Cell Lung Cancer (NSCLC)United States, Canada, France, Singapore, Taiwan
-
Acceleron Pharma Inc. (a wholly owned subsidiary...Terminated
-
Sichuan Haisco Pharmaceutical Group Co., LtdCompletedDiabetes Mellitus, Type 2China
-
University of Sao Paulo General HospitalRecruitingCoronary Artery Disease | Diabetes Mellitus, Type 2 | Acute Kidney Injury | Coronary Artery Bypass SurgeryBrazil
-
Medical College of WisconsinTerminatedLymphoma | Myelodysplastic Syndromes | Acute Leukemia | Chronic LeukemiaUnited States
-
Daiichi SankyoAstraZenecaActive, not recruitingAdvanced Colorectal CancerKorea, Republic of, United States, Taiwan, Belgium, Spain, Japan, United Kingdom, France, Italy, Australia
-
Region SkaneTerminatedCarcinoma | Metastatic Cancer | Thyroid Neoplasms | Thyroid CancerSweden
-
Stanford UniversityCompletedPre-operative Prophylaxis With Vancomycin and Cefazolin in Pediatric Cardiovascular Surgery PatientsAortic Valve Disorder | Congenital Heart DiseasesUnited States
-
Karolinska InstitutetKarolinska University HospitalRecruiting
-
University Health Network, TorontoActive, not recruitingAxial SpondyloarthritisCanada
-
National Research Center for Hematology, RussiaNot yet recruitingHematologic Malignancy | Graft Versus Host Disease | Cyclophosphamide Adverse Reaction
-
The Netherlands Cancer InstituteRoche Pharma AG; Borstkanker Onderzoek GroepActive, not recruitingBreast Cancer | HER2 PositiveNetherlands
-
King Faisal UniversityCompleted
-
Hospital Clinic of BarcelonaAgencia Española de Cooperación Internacional; World Health OrganizationTerminated
-
University of CalgarySage Products, Inc.CompletedOral Hygiene | Ventilator Associated PneumoniaCanada
-
Hospices Civils de LyonUnknownSystemic Wegener's GranulomatosisFrance
-
Hoffmann-La RocheRoche Pharma AGCompletedMetastatic Breast CancerItaly, Spain, Canada, United States, Belgium, France, Germany
-
AB FoundationCompleted
-
All India Institute of Medical Sciences, New DelhiCompletedTuberculosis | Drug Induced HepatotoxicityIndia
-
University of GiessenCompletedNon-Hodgkin's Lymphoma | Mantle Cell LymphomaGermany
-
Spanish Clinical Pharmacology SocietySpanish reumatology SocietyCompleted
-
Karolinska InstitutetTerminatedFemoral FractureSweden
-
Nivagen Pharmaceuticals Inc.CompletedInternal HemorrhoidsUnited States, India
-
Beijing Tiantan HospitalCompletedIschemic Stroke, AcuteChina
-
Vejle HospitalCompleted
-
Yale UniversityNational Institute on Alcohol Abuse and Alcoholism (NIAAA)Not yet recruitingAlcohol-Related Disorders | Alcohol Use | Alcohol Use Disorder (AUD)United States
-
West Japan Thoracic Oncology GroupCompleted
-
New York Institute of TechnologyStony Brook UniversityUnknown
-
Medical University of ViennaCompleted
-
Royal Marsden NHS Foundation TrustHoffmann-La Roche; Professor Cunningham's Clinical Research FundCompletedPancreatic CancerUnited Kingdom
-
Mayo ClinicTerminatedHead and Neck CancerUnited States
-
Tokat Gaziosmanpasa UniversityCompletedThird Molar SurgeryTurkey
-
Medical University of ViennaPolymun Scientific, Vienna, AustriaCompleted
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingRefractory Hodgkin Lymphoma | Refractory T-Cell Non-Hodgkin Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Recurrent T-Cell Non-Hodgkin LymphomaUnited States
-
QuantumLeap Healthcare CollaborativeRecruitingBreast Cancer | Breast Neoplasms | Breast Tumors | HER2-positive Breast Cancer | Angiosarcoma | Locally Advanced Breast Cancer | HER2-negative Breast Cancer | TNBC - Triple-Negative Breast Cancer | Hormone Receptor Positive Tumor | Hormone Receptor Negative Tumor | Early-stage Breast CancerUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)WithdrawnRecurrent B-Cell Non-Hodgkin Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Recurrent T-Cell Non-Hodgkin Lymphoma | Recurrent High Grade B-Cell Lymphoma | Recurrent Aggressive Non-Hodgkin Lymphoma | Recurrent Burkitt Lymphoma | Recurrent Transformed B-Cell Non-Hodgkin LymphomaUnited States
-
UMC UtrechtNational University Hospital, Singapore; Berry Consultants; University of Pittsburgh... and other collaboratorsRecruitingCommunity-acquired Pneumonia, Influenza, COVID-19United Kingdom, United States, Canada, Australia, Netherlands, Croatia, Germany, Belgium, New Zealand, Ireland, Spain, Japan, Hungary, Colombia, India, Nepal, Pakistan, Portugal, Romania, Saudi Arabia